Long term follow-up of refractory/relapsed acute myeloid leukemia patients treated with the FLAG-Ida regimen as bridge therapy to allotransplantation: 10-year results from a single centre experience

Leuk Res. 2023 Jun:129:107069. doi: 10.1016/j.leukres.2023.107069. Epub 2023 Mar 24.

¹ Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy. Electronic address: mario.delia74@gmail.com.
² Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy.
³ Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), "Aldo Moro" University - School of Medicine, Bari, Italy.
⁴ Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), "Aldo Moro" University - School of Medicine, Bari, Italy.

No abstract available

Keywords: Acute myeloid leukemia; Allotransplant; FLAG-Ida.

Publication types